Obtaining of the pharmacopoeial reference sample of the mandelic acid isopropyl ester
DOI:
https://doi.org/10.24959/nphj.18.2196Keywords:
UDC 547.588.11, 54.057, 006.034Abstract
In accordance with the requirements of the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) each monograph for a drug must include the test for related impurities. Impurities in a medicinal product may appear as initial, intermediate or side products of the synthesis and during storage.
Aim. To obtain the impurity of the pregabalin substance – a high-purity isopropyl ester of mandelic acid in order to provide the domestic pharmaceutical market with the pharmacopoeial reference sample of the State Pharmacopoeia of Ukraine (RS SPhU) in the framework of the program for import substitution of reference samples.
Materials and methods. To obtain RS SPhU of the mandelic acid isopropyl ester the traditional methods of organic synthesis, X-ray diffraction analysis, 1H and 13C NMR-spectroscopy, absorption spectrophotometry in the infrared region, thermogravimetry, the capillary method for determining the melting point, thin-layer and liquid chromatography were used, determination of water was performed by K. Fischer titration.
Results and discussion. The simple method for the synthesis of 1-methylethyl-(2RS)-2-hydroxy-2-phenylacetate with mandelic acid and 2-propanol in the presence of catalytic amounts of inorganic acids, as well as its subsequent purification with a final yield of over 90 % have been proposed.
Conclusions. As a result of the study isopropyl ester of mandelic acid has been synthesized, and the effective method of its purification providing a high degree of purity of the target compound has been selected. By its characteristics the substance obtained fully complies with the requirements of the LGC international certificate as a RS and can be used for the qualitative and quantitative determination of a related impurity in the pregabalin substance.
References
Leontev, D. A., Volovyk, N. V., Gryzodub, A. I. (2015). Farmatcevticheskii zhurnal (Uzbekistan), 2, 29–37.
2. European Pharmacopoeia Supplement, 8.7–th ed. (2016).Strasbourg: European Department for the Quality of Medicines, 5801–5803.
3. ISO Guide 34:2009(E): General requirements for the competence of reference material producers. (2009).Geneva: International Organization for Standardization. ISO copyright office, 34.
4. Derzhavna Farmakopeia Ukrainy, v 3–kh tomakh. (2015). Kharkiv: Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv, 1, 1128.
5. European Pharmacopoeia Supplement, 9.3–th ed. (2017).Strasbourg: European Department for the Quality of Medicines.
Likhar, P. R., Bandyopadhyay, A. K. (2008). YCl3–Catalyzed Highly Selective Conversion of Arylglyoxal toα–Aryl–α–Hydroxyacetic Ester: Dramatic Influence of Base. Synlett, 2000 (04), 538–540. doi: 10.1055/s–2000–6569
Jaoui, M., Kleindienst, T. E., Lewandowski, M., Edney, E. O. (2004). Identification and Quantification of Aerosol Polar Oxygenated Compounds Bearing Carboxylic or Hydroxyl Groups. 1. Method Development. Analytical Chemistry, 76 (16), 4765–4778. doi: 10.1021/ac049919h
Houston, T. A., Wilkinson, B. L., Blanchfield, J. T. (2004). Boric Acid Catalyzed Chemoselective Esterification of α–Hydroxycarboxylic Acids. Organic Letters, 6 (5), 679–681. doi: 10.1021/ol036123g
Patel, D. A., Patel, A. A., Patel, H. S. (2017). Synthetic, spectroscopic, magnetic and thermal aspects of drug based metal complexes derived from 1st row transition metal ions. Arabian Journal of Chemistry, 10, S2217–S2224. doi: 10.1016/j.arabjc.2013.07.056
Becker, H. G. O., Berger, W., Domschke, G. et al. (2015). Organikum: Organisch–chemisches. Wiley–VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 46–51.
Günther, H. (2013). NMR Spectroscopy: Basic Principles, Concepts and Applications in Chemistry, 3rd ed. Wiley–VCH: Weinheim, Germany, 85–148.
Berger, S., Braun, S. (2004). 200 and More NMR Experiments: A Practical Course, 3rd edition. Wiley–VCH,Weinheim,Germany, 838.
Isaiev, I., Shishkina, S., Ukrainets, I., Bevz, E. (2017). Crystalstructure of isopropyl 2–hydroxy–2–phenylacetate: a pharmacopoeia reference standard. Acta Crystallographica Section E Crystallographic Communications, 73 (5), 771–773. doi: 10.1107/s2056989017005862
Yadav, A., Shete, A., Dabke, A., Kulkarni, P., Sakhare, S. (2009). Co–crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian Journal of Pharmaceutical Sciences, 71 (4), 359. doi: 10.4103/0250–474x.57283
Pradyot, P. (2003). Handbook of inorganic chemicals. McGraw–Hill Companies, 161–163.
16. LGC Certificate of Analysis. Reference Standard. Propan–2–yl (2RS)–2–Hydroxy–2–phenylacetate (Isopropyl Mandelate). Available at: https://hybris–static–assets–production.s3–eu–west–1.amazonaws.com/sysmaster/pdfs/ha1/h83/9439015829534/en_ST–WB–CERT–2387565–1–1–1.PDF
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
